231 related articles for article (PubMed ID: 37931130)
1. Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.
Narayanan KK; Amaya M; Tsang N; Yin R; Jays A; Broder CC; Shukla D; Procko E
J Virol; 2023 Nov; 97(11):e0062123. PubMed ID: 37931130
[TBL] [Abstract][Full Text] [Related]
2. The Sequence Basis for Selectivity of Ephrin-B2 Ligand for Eph Receptors and Pathogenic Henipavirus G Glycoproteins: Selective Ephrin-B2 Decoys for Nipah and Hendra Virus.
Narayanan KK; Amaya M; Tsang N; Yin R; Jays A; Broder CC; Shukla D; Procko E
bioRxiv; 2023 Apr; ():. PubMed ID: 37162958
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
5. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2.
Xu K; Chan YP; Rajashankar KR; Khetawat D; Yan L; Kolev MV; Broder CC; Nikolov DB
PLoS One; 2012; 7(11):e48742. PubMed ID: 23144952
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.
Bowden TA; Aricescu AR; Gilbert RJ; Grimes JM; Jones EY; Stuart DI
Nat Struct Mol Biol; 2008 Jun; 15(6):567-72. PubMed ID: 18488039
[TBL] [Abstract][Full Text] [Related]
7. Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays.
Yang M; Zhu W; Truong T; Pickering B; Babiuk S; Kobasa D; Banadyga L
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016279
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of interaction between Nipah virus attachment glycoprotein and host cell receptors Ephrin-B2 and Ephrin-B3 in domestic and peridomestic mammals.
Hoque AF; Rahman MM; Lamia AS; Islam A; Klena JD; Satter SM; Epstein JH; Montgomery JM; Hossain ME; Shirin T; Jahid IK; Rahman MZ
Infect Genet Evol; 2023 Dec; 116():105516. PubMed ID: 37924857
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection.
Yuan J; Marsh G; Khetawat D; Broder CC; Wang LF; Shi Z
J Gen Virol; 2011 Sep; 92(Pt 9):2142-2152. PubMed ID: 21632558
[TBL] [Abstract][Full Text] [Related]
10. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.
Xu K; Broder CC; Nikolov DB
Semin Cell Dev Biol; 2012 Feb; 23(1):116-23. PubMed ID: 22227101
[TBL] [Abstract][Full Text] [Related]
11. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.
Bonaparte MI; Dimitrov AS; Bossart KN; Crameri G; Mungall BA; Bishop KA; Choudhry V; Dimitrov DS; Wang LF; Eaton BT; Broder CC
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10652-7. PubMed ID: 15998730
[TBL] [Abstract][Full Text] [Related]
12. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
13. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
14. A key region of molecular specificity orchestrates unique ephrin-B1 utilization by Cedar virus.
Pryce R; Azarm K; Rissanen I; Harlos K; Bowden TA; Lee B
Life Sci Alliance; 2020 Jan; 3(1):. PubMed ID: 31862858
[TBL] [Abstract][Full Text] [Related]
15. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.
Laing ED; Amaya M; Navaratnarajah CK; Feng YR; Cattaneo R; Wang LF; Broder CC
Virol J; 2018 Mar; 15(1):56. PubMed ID: 29587789
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
17. Structural Studies of Henipavirus Glycoproteins.
May AJ; Acharya P
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399971
[TBL] [Abstract][Full Text] [Related]
18. Henipavirus membrane fusion and viral entry.
Aguilar HC; Iorio RM
Curr Top Microbiol Immunol; 2012; 359():79-94. PubMed ID: 22427111
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation.
Priyadarsinee L; Sarma H; Sastry GN
J Chem Sci (Bangalore); 2022; 134(4):114. PubMed ID: 36465097
[TBL] [Abstract][Full Text] [Related]
20. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
